Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01920932 · BASELINE

Baseline characteristics

Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma · Source last updated 2026-05-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      77
    units
    Participants
groups
  1. description
    Ann Arbor stage IIB, IIIB, IVA, or IVB participants receive: 2 cycles of AEPA chemotherapy: (A) Brentuximab vedotin 1.2 mg/kg IV (intravenous) days 1, 8 and 15, (E) Etoposide 125 mg/m\^2 IV days 1-5, (P) Prednisone 60 mg/m\^2/day PO (orally) days 1-15, (A) Doxorubicin 40 mg/m\^2 IV days 1 and 15), Followed by 4 cycles of CAPDac: (C) Cyclophosphamide 500 mg/m\^2 IV days 1 and 8, (A) Brentuximab vedotin 1.2 mg/kg IV days 1 and 8, (P) Prednisone 40 mg/m\^2/day PO days 1-15, (Dac) Dacarbazine 250 mg/m\^2 IV days 1-3.). Filgrastim 5 mcg/kg subcutaneous (SC) as clinically indicated. For those with lymph nodes that do not go into remission after 2 courses of AEPA chemotherapy, radiation therapy is given.
    id
    BG000
    title
    AEPA/CAPDac
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          6
          upper Limit
          19
          value
          16
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          39
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          38
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          4
      title
      Asian
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          17
      title
      Black or African American
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          50
      title
      White
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          4
      title
      More than one race
    5. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      Others
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          59
        title
        St. Jude Children's Research Hospital
      2. measurements
        1. group Id
          BG000
          value
          9
        title
        Stanford University Medical Center
      3. measurements
        1. group Id
          BG000
          value
          4
        title
        Dana Farber Cancer Institute
      4. measurements
        1. group Id
          BG000
          value
          1
        title
        Maine Medical Center
      5. measurements
        1. group Id
          BG000
          value
          2
        title
        Massachusetts General Hospital
      6. measurements
        1. group Id
          BG000
          value
          2
        title
        St. Jude Midwest Affiliate
      title
      United States
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Region of Enrollment
    unit Of Measure
    Participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          59
      title
      Nodular sclerosing
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          11
      title
      Classical, NOS
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          4
      title
      Lymphocyte rich
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Mixed cellularity
    description
    Abbreviation: NOS, not otherwise specified.
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Histology
    unit Of Measure
    Participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          13
      title
      IIB
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          19
      title
      IIIB
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          12
      title
      IVA
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          33
      title
      IVB
    description
    II: Involvement of 2 or more lymph node regions on the same side of the diaphragm (II) or localized contiguous involvement of a single extra-lymphatic organ or site and its regional lymph node(s) III: Involvement of lymph node regions on both sides of the diaphragm (III), which may also be accompanied by localized contiguous involvement of an extra-lymphatic organ or site (IIIE) IV: Disseminated (multifocal) involvement of 1 or more extra-lymphatic organs or tissues, with/without associated lymph node involvement, or isolated extra-lymphatic organ involvement with distant nodal involvement
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Stage
    unit Of Measure
    Participants
population Description
For staging: B symptoms (unexplained fevers, drenching night sweats or \> 10% weight loss). A= absence of B symptoms
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      77
    units
    Participants
groups
  1. description
    Ann Arbor stage IIB, IIIB, IVA, or IVB participants receive: 2 cycles of AEPA chemotherapy: (A) Brentuximab vedotin 1.2 mg/kg IV (intravenous) days 1, 8 and 15, (E) Etoposide 125 mg/m\^2 IV days 1-5, (P) Prednisone 60 mg/m\^2/day PO (orally) days 1-15, (A) Doxorubicin 40 mg/m\^2 IV days 1 and 15), Followed by 4 cycles of CAPDac: (C) Cyclophosphamide 500 mg/m\^2 IV days 1 and 8, (A) Brentuximab vedotin 1.2 mg/kg IV days 1 and 8, (P) Prednisone 40 mg/m\^2/day PO days 1-15, (Dac) Dacarbazine 250 mg/m\^2 IV days 1-3.). Filgrastim 5 mcg/kg subcutaneous (SC) as clinically indicated. For those with lymph nodes that do not go into remission after 2 courses of AEPA chemotherapy, radiation therapy is given.
    id
    BG000
    title
    AEPA/CAPDac
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          6
          upper Limit
          19
          value
          16
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          39
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          38
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          4
      title
      Asian
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          17
      title
      Black or African American
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          50
      title
      White
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          4
      title
      More than one race
    5. categories
      1. measurements
        1. group Id
          BG000
          value
          2
      title
      Others
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Race/Ethnicity, Customized
    unit Of Measure
    Participants
  4. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          59
        title
        St. Jude Children's Research Hospital
      2. measurements
        1. group Id
          BG000
          value
          9
        title
        Stanford University Medical Center
      3. measurements
        1. group Id
          BG000
          value
          4
        title
        Dana Farber Cancer Institute
      4. measurements
        1. group Id
          BG000
          value
          1
        title
        Maine Medical Center
      5. measurements
        1. group Id
          BG000
          value
          2
        title
        Massachusetts General Hospital
      6. measurements
        1. group Id
          BG000
          value
          2
        title
        St. Jude Midwest Affiliate
      title
      United States
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Region of Enrollment
    unit Of Measure
    Participants
  5. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          59
      title
      Nodular sclerosing
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          11
      title
      Classical, NOS
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          4
      title
      Lymphocyte rich
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          3
      title
      Mixed cellularity
    description
    Abbreviation: NOS, not otherwise specified.
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Histology
    unit Of Measure
    Participants
  6. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          13
      title
      IIB
    2. categories
      1. measurements
        1. group Id
          BG000
          value
          19
      title
      IIIB
    3. categories
      1. measurements
        1. group Id
          BG000
          value
          12
      title
      IVA
    4. categories
      1. measurements
        1. group Id
          BG000
          value
          33
      title
      IVB
    description
    II: Involvement of 2 or more lymph node regions on the same side of the diaphragm (II) or localized contiguous involvement of a single extra-lymphatic organ or site and its regional lymph node(s) III: Involvement of lymph node regions on both sides of the diaphragm (III), which may also be accompanied by localized contiguous involvement of an extra-lymphatic organ or site (IIIE) IV: Disseminated (multifocal) involvement of 1 or more extra-lymphatic organs or tissues, with/without associated lymph node involvement, or isolated extra-lymphatic organ involvement with distant nodal involvement
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Stage
    unit Of Measure
    Participants
population Description
For staging: B symptoms (unexplained fevers, drenching night sweats or \> 10% weight loss). A= absence of B symptoms

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice